CLAIM CARD
The evidence base for rapamycin's contextual effects spans diverse study designs, populations, and endpoints across the 16 curated references. Gkioni 2025 demonstrated that rapamycin combined additively with trametinib to extend mouse healthspan and lifespan, with effects reaching significance on multiple endpoints.
Evidence grade: exploratory
Contradiction status: none
Publication: 1ece772b-d3e4-4ad0-b090-ac7e9ea4a1d6
Provenance: Derivation Web chain
Citation Support
source_1Mandrioli 2023source_2Lin 2022source_3Moel 2025source_4Gkioni 2025source_5Zhou 2024